Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Antimicrobial Resistance

University of Guelph

$100,000.00

CRISPR-based genetic interactions analysis in fungal pathogens: new approaches for identifying antifungal drug targets

FY 2017-18

Summary
Combating infectious diseases and drug-resistant microbial pathogens is one the most important global health challenges being faced today - in Canada, and throughout the world. Understanding the biological mechanisms underscoring microbial virulence and resistance to antimicrobial agents is of critical and immediate importance. Pathogenic fungi are a growing public health concern, and have emerged as a leading cause of human mortality, particularly among the ever-increasing population of immunocompromised individuals. The treatment of fungal infections is notoriously challenging, with a very limited selection of clinically effective, nontoxic antifungal therapeutic options, and increasing rates of antifungal drug resistance. My research program aims to improve our ability to understand how fungi cause disease, and resist treatment with antifungals, through the development and use of cutting-edge CRISPR-based genome editing technologies. Focusing on Candida albicans, the most common cause of fungal infections, and Candida auris, an emerging fungal pathogen and critical public health threat, we will develop CRISPR systems to create genetic mutants on a large scale, and use these to explore the genetic mechanisms by which Candida species are able to tolerate treatment with antifungal drugs and cause life-threatening disease.
Program
Project Grant - Priority Announcement: Antimicrobial Resistance
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
384986
Name
Shapiro Rebecca S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
CRISPR-based genetic interactions analysis in fungal pathogens: new approaches for identifying antifungal drug targets
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Antimicrobial Resistance
Keyworddelim
Antifungal Drug Resistance; Candida Albicans; Crispr; Functional Genomics; Fungal Genetics; Fungal Pathogens; Fungal Virulence
Abstract
Combating infectious diseases and drug-resistant microbial pathogens is one the most important global health challenges being faced today - in Canada, and throughout the world. Understanding the biological mechanisms underscoring microbial virulence and resistance to antimicrobial agents is of critical and immediate importance. Pathogenic fungi are a growing public health concern, and have emerged as a leading cause of human mortality, particularly among the ever-increasing population of immunocompromised individuals. The treatment of fungal infections is notoriously challenging, with a very limited selection of clinically effective, nontoxic antifungal therapeutic options, and increasing rates of antifungal drug resistance. My research program aims to improve our ability to understand how fungi cause disease, and resist treatment with antifungals, through the development and use of cutting-edge CRISPR-based genome editing technologies. Focusing on Candida albicans, the most common cause of fungal infections, and Candida auris, an emerging fungal pathogen and critical public health threat, we will develop CRISPR systems to create genetic mutants on a large scale, and use these to explore the genetic mechanisms by which Candida species are able to tolerate treatment with antifungal drugs and cause life-threatening disease.
Competitiondate
201803
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shapiro, Rebecca S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Guelph - $100,000 Grant (2017-18) | Canada Spends